Abraham Johannes De Smit

Title: Abraham Johannes De Smit: Innovator in Antibody and Viral Vector Technologies

Introduction

Abraham Johannes De Smit is a notable inventor based in Wijchen, Netherlands. He has made significant contributions to the fields of biotechnology and pharmaceuticals, particularly in the development of innovative antibody technologies and viral vector systems. With a total of 2 patents, his work has the potential to impact medical treatments and vaccine development.

Latest Patents

De Smit's latest patents include groundbreaking inventions such as "Single domain antibodies binding to tetanus neurotoxin." This invention focuses on single domain antibodies (SDAs) that can effectively bind to tetanus neurotoxin. It also encompasses polypeptide constructs that include such SDAs, as well as nucleic acids encoding these constructs. The medical applications of this invention are significant, particularly in the treatment of tetanus.

Another notable patent is "Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom." This invention relates to the expression of exogenous feline paramyxovirus genes through recombinant viral vector systems, which could lead to advancements in vaccine development.

Career Highlights

Throughout his career, De Smit has worked with various companies, including Smivet B.V. His expertise in biotechnology has allowed him to contribute to innovative projects that enhance medical treatments and vaccine efficacy.

Collaborations

De Smit has collaborated with esteemed colleagues such as Michaël Marie Harmsen and Hervé Poulet. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Abraham Johannes De Smit is a prominent inventor whose work in antibody and viral vector technologies holds promise for future medical advancements. His contributions are paving the way for new treatments and vaccines that could significantly improve public health.